caix (Novus Biologicals)
Structured Review

Caix, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ca9/Carbonic+Anhydrase+IX%2FCA9+Antibody+-+BSA+Free/pmc03848446-186-9-13
Average 96 stars, based on 327 article reviews
Images
1) Product Images from "Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?"
Article Title: Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?
Journal: Journal of Translational Medicine
doi: 10.1186/1479-5876-11-214
Figure Legend Snippet: Summary of the immunocytochemical analysis of CNHCs with antibodies against CD45, CD31, and CAIX
Techniques Used:
Figure Legend Snippet: Immunocytochemical analysis of CNHCs with antibodies against the RCC marker CAIX. Clusters of CNHCs cytomorphologically classified as uncertain malignant (−UMF) with cytoplasmic positive staining with antibodies against the RCC marker CAIX (A) . Clusters of CNHC-UMF and -BF without reactivity for CAIX antibodies ( B and C , respectively). A single CNHC-MF with positive cytoplasmic (D) and without staining for CAIX (E) . Single CAIX-negative CNHC-UMF and -BF ( F and G , respectively).
Techniques Used: Marker, Staining
Related Articles
Western Blot:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Generated:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Immunoprecipitation:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Luciferase:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Chromatin Immunoprecipitation:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Blocking Assay:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Saline:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Polymer:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Incubation:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Expressing:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Next-Generation Sequencing:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, Staining:Article Title: COVID-19 triggers pulmonary tumor outgrowth through hypoxia- and inflammation-induced VEGF-dependent angiogenesis Article Snippet: sher Scientific), CD86 (1:100, 19589, Cell Signaling), FAP (1:200, MAB9727, R&D Systems), α-SMA (1:200, MA5-11547, Thermo Fisher Scientific), desmin (1:200, MAB3430, Millipore), CA9 (1:300, |
